Variability of Steroid Prescription for COVID-19 Associated Pneumonia in Real-Life, Non-Trial Settings

The RECOVERY study documented lower 28-day mortality with the use of dexamethasone in hospitalized patients on invasive mechanical ventilation or oxygen with COVID-19 Pneumonia. We aimed to examine the practice patterns of steroids use, and their impact on mortality and length of stay in ICU. We ret...

Full description

Bibliographic Details
Main Authors: Nadeem Rashid, Bon Islam, Algohary Doaa, Kafeel Khan Mohd, Gundawar Nilesh, Abdullah Mohammed, Sharma Ekta, Galal Elzeiny Moatz, Mahmoud Mayada, Elhoufi Ashraf, Alshaikh Sayed Ahmed Yusra Omar, Gheno Gloria, Salama Khalil Maged Talaat, Hussain Tamseela
Format: Article
Language:English
Published: Sciendo 2022-11-01
Series:The Journal of Critical Care Medicine
Subjects:
Online Access:https://doi.org/10.2478/jccm-2022-0025
_version_ 1797427035104083968
author Nadeem Rashid
Bon Islam
Algohary Doaa
Kafeel Khan Mohd
Gundawar Nilesh
Abdullah Mohammed
Sharma Ekta
Galal Elzeiny Moatz
Mahmoud Mayada
Elhoufi Ashraf
Alshaikh Sayed Ahmed Yusra Omar
Gheno Gloria
Salama Khalil Maged Talaat
Hussain Tamseela
author_facet Nadeem Rashid
Bon Islam
Algohary Doaa
Kafeel Khan Mohd
Gundawar Nilesh
Abdullah Mohammed
Sharma Ekta
Galal Elzeiny Moatz
Mahmoud Mayada
Elhoufi Ashraf
Alshaikh Sayed Ahmed Yusra Omar
Gheno Gloria
Salama Khalil Maged Talaat
Hussain Tamseela
author_sort Nadeem Rashid
collection DOAJ
description The RECOVERY study documented lower 28-day mortality with the use of dexamethasone in hospitalized patients on invasive mechanical ventilation or oxygen with COVID-19 Pneumonia. We aimed to examine the practice patterns of steroids use, and their impact on mortality and length of stay in ICU. We retrospectively examined records of all patients with confirmed Covid 19 pneumonia admitted to the ICU of Dubai hospital from January 1st, 2020 – June 30th, 2020. We assigned patients to four groups (No steroids, low dose, medium dose, and high dose steroids). The primary clinical variable of interest was doses of steroids. Secondary outcomes were 28-day mortality and length of stay in ICU”. We found variability in doses of steroid treatment. The most frequently used dose was the high dose. Patients who survived were on significantly higher doses of steroids and had significantly longer stays in ICU. The prescription of steroids in Covid-19 ARDS is variable. The dose of steroids impacts mortality rate and length of stay in ICU, although patients treated with high dose steroids seem to stay more days in ICU.
first_indexed 2024-03-09T08:38:27Z
format Article
id doaj.art-068aab1e94a9499ba635d47ae5227dee
institution Directory Open Access Journal
issn 2393-1817
language English
last_indexed 2024-03-09T08:38:27Z
publishDate 2022-11-01
publisher Sciendo
record_format Article
series The Journal of Critical Care Medicine
spelling doaj.art-068aab1e94a9499ba635d47ae5227dee2023-12-02T17:28:05ZengSciendoThe Journal of Critical Care Medicine2393-18172022-11-018425926510.2478/jccm-2022-0025Variability of Steroid Prescription for COVID-19 Associated Pneumonia in Real-Life, Non-Trial SettingsNadeem Rashid0Bon Islam1Algohary Doaa2Kafeel Khan Mohd3Gundawar Nilesh4Abdullah Mohammed5Sharma Ekta6Galal Elzeiny Moatz7Mahmoud Mayada8Elhoufi Ashraf9Alshaikh Sayed Ahmed Yusra Omar10Gheno Gloria11Salama Khalil Maged Talaat12Hussain Tamseela13Dubai Hospital, Dubai, UAE, United Arab EmiratesDubai Hospital, Dubai, UAE, United Arab EmiratesDubai Hospital, Dubai, UAE, United Arab EmiratesDubai Hospital, Dubai, UAE, United Arab EmiratesDubai Hospital, Dubai, UAE, United Arab EmiratesDubai Hospital, Dubai, UAE, United Arab EmiratesDubai Hospital, Dubai, UAE, United Arab EmiratesDubai Hospital, Dubai, UAE, United Arab EmiratesDubai Hospital, Dubai, UAE, United Arab EmiratesDubai Hospital, Dubai, UAE, United Arab EmiratesDubai Hospital, Dubai, UAE, United Arab EmiratesRonin Institute for Independent Scholarship, Montclair, New Jersey, USADubai Hospital, Dubai, UAE, United Arab EmiratesRonin Institute for Independent Scholarship, Montclair, New Jersey, USAThe RECOVERY study documented lower 28-day mortality with the use of dexamethasone in hospitalized patients on invasive mechanical ventilation or oxygen with COVID-19 Pneumonia. We aimed to examine the practice patterns of steroids use, and their impact on mortality and length of stay in ICU. We retrospectively examined records of all patients with confirmed Covid 19 pneumonia admitted to the ICU of Dubai hospital from January 1st, 2020 – June 30th, 2020. We assigned patients to four groups (No steroids, low dose, medium dose, and high dose steroids). The primary clinical variable of interest was doses of steroids. Secondary outcomes were 28-day mortality and length of stay in ICU”. We found variability in doses of steroid treatment. The most frequently used dose was the high dose. Patients who survived were on significantly higher doses of steroids and had significantly longer stays in ICU. The prescription of steroids in Covid-19 ARDS is variable. The dose of steroids impacts mortality rate and length of stay in ICU, although patients treated with high dose steroids seem to stay more days in ICU.https://doi.org/10.2478/jccm-2022-0025covid-19infectionsteroidsards
spellingShingle Nadeem Rashid
Bon Islam
Algohary Doaa
Kafeel Khan Mohd
Gundawar Nilesh
Abdullah Mohammed
Sharma Ekta
Galal Elzeiny Moatz
Mahmoud Mayada
Elhoufi Ashraf
Alshaikh Sayed Ahmed Yusra Omar
Gheno Gloria
Salama Khalil Maged Talaat
Hussain Tamseela
Variability of Steroid Prescription for COVID-19 Associated Pneumonia in Real-Life, Non-Trial Settings
The Journal of Critical Care Medicine
covid-19
infection
steroids
ards
title Variability of Steroid Prescription for COVID-19 Associated Pneumonia in Real-Life, Non-Trial Settings
title_full Variability of Steroid Prescription for COVID-19 Associated Pneumonia in Real-Life, Non-Trial Settings
title_fullStr Variability of Steroid Prescription for COVID-19 Associated Pneumonia in Real-Life, Non-Trial Settings
title_full_unstemmed Variability of Steroid Prescription for COVID-19 Associated Pneumonia in Real-Life, Non-Trial Settings
title_short Variability of Steroid Prescription for COVID-19 Associated Pneumonia in Real-Life, Non-Trial Settings
title_sort variability of steroid prescription for covid 19 associated pneumonia in real life non trial settings
topic covid-19
infection
steroids
ards
url https://doi.org/10.2478/jccm-2022-0025
work_keys_str_mv AT nadeemrashid variabilityofsteroidprescriptionforcovid19associatedpneumoniainreallifenontrialsettings
AT bonislam variabilityofsteroidprescriptionforcovid19associatedpneumoniainreallifenontrialsettings
AT algoharydoaa variabilityofsteroidprescriptionforcovid19associatedpneumoniainreallifenontrialsettings
AT kafeelkhanmohd variabilityofsteroidprescriptionforcovid19associatedpneumoniainreallifenontrialsettings
AT gundawarnilesh variabilityofsteroidprescriptionforcovid19associatedpneumoniainreallifenontrialsettings
AT abdullahmohammed variabilityofsteroidprescriptionforcovid19associatedpneumoniainreallifenontrialsettings
AT sharmaekta variabilityofsteroidprescriptionforcovid19associatedpneumoniainreallifenontrialsettings
AT galalelzeinymoatz variabilityofsteroidprescriptionforcovid19associatedpneumoniainreallifenontrialsettings
AT mahmoudmayada variabilityofsteroidprescriptionforcovid19associatedpneumoniainreallifenontrialsettings
AT elhoufiashraf variabilityofsteroidprescriptionforcovid19associatedpneumoniainreallifenontrialsettings
AT alshaikhsayedahmedyusraomar variabilityofsteroidprescriptionforcovid19associatedpneumoniainreallifenontrialsettings
AT ghenogloria variabilityofsteroidprescriptionforcovid19associatedpneumoniainreallifenontrialsettings
AT salamakhalilmagedtalaat variabilityofsteroidprescriptionforcovid19associatedpneumoniainreallifenontrialsettings
AT hussaintamseela variabilityofsteroidprescriptionforcovid19associatedpneumoniainreallifenontrialsettings